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Abstract
Dietary flavonoids, including the citrus flavanone hesperetin, may have stimulatory 
effects on cytoprotective intracellular signalling pathways.  In primary mouse cortical 
neurone cultures, but not SH-SY5Y human neuroblastoma cells or human primary 
dermal fibroblasts (Promocells), hesperetin (100 – 300 nM, 15 min) caused significant 
increases in the level of ERK1/2 phosphorylation, but did not increase CREB 
phosphorylation. Administration of hesperetin for 18 h did not alter gene expression 
driven by the Cyclic AMP Response Element (CRE), assessed using a luciferase 
reporter system, but 300 nM hesperetin partially reversed staurosporine-induced cell 
death in primary neurones. Our data show that hesperetin is a neuroprotective 
compound at concentrations where antioxidant effects are unlikely to predominate. The 
effects of hesperetin are cell-type dependent and, unlike the flavanol (-)epicatechin, 
neuroprotection in vitro is not associated with enhanced CREB phosphoryation or 
CRE-mediated gene expression.
Introduction
Consumption of dietary flavonoids has been associated with reduced risk of 
neurodegenerative diseases in man [15,25,30] neuroprotection against disease-relevant 
insults in mice or rats [8,12,13, 19] and improvements in cognition and learning in 
animal models [7,8,14,26,29].  The mechanisms are often assumed to involve the 
hydrogen-donating antioxidant activities of flavonoids but, in addition to their 
antioxidant effects, flavonoids at low concentrations can also modulate intracellular 
3signalling pathways [31].  Several flavonoids have been shown to influence one or 
more components of cytoprotective intracellular signalling cascades including 
phosphatidylinositol 3-kinase (PI 3-kinase), tyrosine kinases and MAP kinases 
[1,21,23,24,27,28,32].   
(-)Epicatechin is one of the most important bioactive flavonoids derived from a 
flavanol-rich diet [24].  When applied to primary cortical neurones at concentrations of 
100-300 nM for 15 min, (-)epicatechin produces rapid phosphorylation of ERK and 
CREB, two components of the pro-survival mitogen activated protein kinase signalling 
cascade and enhances cyclic AMP response element-mediated gene expression in 
neurones [23].  However, there are five other major families of flavonoids and 
phenolics in the human diet, and relatively little information to date as to whether 
flavonoids of different classes act through similar or distinct intracellular cellular 
mechanisms, and whether those mechanisms are universal or found only in some 
cell-types.  The flavanone hesperetin is the major circulating aglycone metabolite of
hesperidin, abundant in citrus fruit and drinks [6,9]. Hesperetin in vitro is known to act 
as an antioxidant and scavenger of peroxynitrite [3,18,19] and might modulate 
signalling pathways in an analogous way to (-)epicatechin.  For example, in fibroblasts 
and neurones in vitro, hesperetin can promote ERK phosphorylation [18,27].  In vivo, 
hesperetin feeding to rats suppressed kidney NfB-mediated gene expression through 
modulation of ERK, JNK and p38 pathways [10].  
Recently, hesperetin has been reported to afford neuroprotection in vitro through an 
Akt- and ERK-dependent mechanism [27], but whether this involves the activation of 
CREB, as previously shown for (-)epicatechin, is not known.  The main aim of the 
4study was to test this possibility and to characterise whether the effects of hesperetin 
extend to other cell types as well as cortical neurones.
Materials and Methods
Materials. All reagents, unless specified, were from Sigma or Merck.
Cell Culture. Primary cortical neurones were prepared from 15-16 day old Swiss 
mouse embryos (NIH, Harlan, UK) as described previously [4]. The SH-SY5Y human 
neuroblastoma cell line was obtained from Dr Peter Vaughan. SH-SY5Y
neuroblastoma were cultured in 1:1 Ham’s F12 medium: Eagle’s MEM supplemented 
with 10% foetal calf serum, 1% non-essential amino acids and 0.1% gentamicin. 
Human dermal fibroblasts were obtained from PromoCell, (Heidelberg, Germany), 
cultured in fibroblast basal medium (PromoCell) supplemented with insulin (5 µg/ml), 
bFGF (1 ng/ml), amphotericin (50 ng/ml) and gentamicin (50 µg/ml). Promocells were 
switched to medium without bFGF 18 h before flavonoid treatment to reduce basal 
protein kinase activity (not shown). 
Flavonoid treatments. (-)epicatechin and hesperetin (Extrasynthase, Genay, France) 
were dissolved in 100% methanol and stored in sealed aliquots at -70oC.  Cells were
washed twice with HEPES-buffered medium (HBM: 20 mM HEPES, 140 mM NaCl, 5 
mM KCl, 1.2 mM CaCl2, 6 mM glucose, 5 mM NaHCO3, 1.2 mM Na2HPO4 pH 7.4) 
before exposure to fresh (-)epicatechin or hesperetin (10 nM - 10 μM) in HBM for 15 
min at 37°C or overnight directly into the growth medium for neuroprotection studies.
Western blotting
5Cells were washed once with ice-cold PBS, pH 7.4, containing EGTA (200 μM) and 
lysed at 4oC in lysis buffer (50 mM Tris, 1% Triton X-100, 150 mM NaCl, 2 mM
EDTA, 2 mM EGTA, 0.5 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml antipain, 2 µg/ml 
pepstatin A, 1 μg/ml chymostatin, 5 mM sodium pyrophosphate, 1 mM Na3V04, and 
50 mM NaF). Lysates were collected and centrifuged at 2000 g (5 min, 4°C), protein 
concentration determined by the BioRad Bradford protein assay. Samples were treated
for 3 min at 95°C in boiling buffer (62.5 mM Tris, pH 6.8, 2% SDS, 5% 
2-mercaptoethanol, 10% glycerol, and 0.0025% bromophenol blue). Samples (30 or 40
μg/lane) were run on 9% SDS-polyacrylamide gels and proteins transferred to 
nitrocellulose membranes (Hybond-ECL; GE Healthcare) by semi-dry electroblotting.  
Membranes were blocked in TBS (20 mM Tris, pH 7.5, 0.5 M NaCl) containing 4% 
skimmed milk powder (25 min) then washed twice in TBS containing 0.05% Tween 20 
(TTBS). The blots were incubated overnight with antibodies in TTBS containing 1% 
skimmed milk powder.  Antisera were anti-ACTIVE MAPK (ERK1/2, Promega, 
1:2500 dilution), anti-ERK 2 (C14, Santa Cruz Biotechnology, 1:1000), anti-phospho-
CREB(Ser133) (Cell Signaling Technology 1:1000) or anti-CREB (Cell Signaling 
Technology 1:1000). Blots were washed twice in TTBS and then incubated with goat 
anti-rabbit IgG peroxidase conjugate (1:1000) in antibody buffer for 45 min. Blots 
were washed twice in TTBS and once in TBS before exposure to ECL Western 
blotting detection reagents and autoradiography (GE Healthcare). Bands were analysed 
using BioImage Intelligent Quantifier software (Bio Image Systems Inc.).  
CRE reporter assay. Cortical neurones cultured in 24 well plates (5 x 105 /well) were 
transfected overnight with 0.25 g of the pCRE-luc cis reporter plasmid (Stratagene) 
and 0.25g of the transfection efficiency Renilla luciferase pRL-TK plasmid 
6(Promega) using 1l LipofectAMINE 2000 (Invitrogen) according to the 
manufacturer's instructions. The growth medium was removed 24 h later and neurones 
stimulated for 15 min at 37oC in HBM containing hesperetin (100 and 300 nM) or 50 
ng/ml brain-derived neurotrophic factor (BDNF, Peprotech). After 15 min the 
compounds were removed and replaced with conditioned medium and the cells 
returned to the CO2 incubator for a further 18 h. Luciferase assays were performed 
using a Dual-Glo luciferase assay system as described in the manufacturer's instructions 
(Promega). Lysates were read in a 96-well luminometer plate (Sigma) and luciferase 
activities produced by the pCRE luciferase reporter plasmid measured using a Veritas 
microplate luminometer (Turner Biosystems Inc.). Renilla luciferase activities 
produced by the pRL-TK control plasmid were then assayed by adding an equal 
volume of Dual-Glo Stop & Glo substrate and measuring again in the luminometer. All 
treatments were performed in quadruplicate on 5-6 independent cultures. Firefly 
luciferase activities were standardized to the corresponding Renilla luciferase 
activities. 
Neuroprotection. Hesperetin was added directly to the culture medium for 24 h before 
neurones were exposed to staurosporine (10 M) for a further 24 h.  Cell viability was 
then assessed by Propidium Iodide - Hoe 33342 double staining and by (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.  For double 
staining the medium was removed and neurones were incubated with Hoe 33342 (10
M, all cells) and propidium iodide (10 M, dead cells) in HBM for 15 min. Cell 
images were captured and the numbers of dead cells relative to total cells were 
quantified using an In Cell Analyser 1000 (GE Healthcare).  MTT turnover was used as 
an indirect measure of cell viability and mitochondrial function. Following exposure to 
7staurosporine, cells were washed twice in PBS before the addition of MTT (0.5 mg/ml) 
in HBM for 60 min at 37oC.  HBM was removed, formazan solubilised in DMSO
(100%) and absorbance read at 505 nm. 
Results
Hesperetin causes concentration-dependent increases in ERK phosphorylation in 
primary neurones, SH-SY5Y and dermal fibroblasts
Mouse primary neurones, human SH-SY5Y neuroblastoma cells or human primary 
dermal fibroblasts (PromoCells) were exposed to a range of concentrations of 
hesperetin (10 nM – 10 M) or (-)epicatechin (10 nM – 10 M) for 15 min.  Primary 
neurones, SH-SY5Y neuroblastoma and human primary dermal fibroblasts when 
exposed to hesperetin all showed increased pERK over a broad concentration range in 
a concentration-related manner. The concentration-dependency responses were 
bell-shaped which is typical for these compounds (Fig 1A). Table 1 shows some of the 
data from these experiments (results using 100 nM, 300 nM, 1 M shown).  While
hesperetin enhanced pERK in each of the three cell types tested, only in primary 
neurones were the increases statistically significant.  In primary neurones, 100 nM 
hesperetin, caused a greater than two-fold increase in pERK levels compared to 
controls, and while pERK levels were increased in dermal fibroblasts and SH-SY5Y 
cells, these increases were not significant (Table 1).  At 10 nM and 10 M, hesperetin 
did not enhance pERK levels (data not shown) in primary neurones or any of the other 
cell types stested.  In primary neurones, 100 nM (-)epicatechin caused a greater than 
threefold increase in pERK (Table 1), and, like hesperetin, produced modest increases 
of pERK in primary dermal fibroblasts and SH-SY5Y neuroblastoma cells.
8Hesperetin does not stimulate CREB phosphorylation or CRE-mediated gene 
expression in primary neurones
We have previously reported that (-)epicatechin stimulates CREB phosphorylation and 
recruitment of CRE-mediated gene expression in primary neurones via a mechanism 
that is partially dependent on ERK and Akt activation [23].  Since hesperetin 
stimulates pERK in neurones, we tested hesperetin (10 nM - 10M, 15 min) for its 
ability to alter the levels of Ser133-phosphorylated CREB (pCREB).  Hesperetin caused 
no increase in the levels of pCREB relative to total CREB (Fig 1B), although 
interestingly at the highest concentration tested (10 M) hesperetin reduced the levels 
of pCREB relative to total CREB. To assess whether hesperetin caused gene 
expression driven by the CRE, primary mouse neurones were co-transfected with a 
CRE-reporter plasmid, which contains firefly luciferase, and a control plasmid 
containing the gene encoding renilla luciferase plasmid as an internal standard.  
Hesperetin at  100 nM and 300 nM (18 h) did not alter the levels of CRE-mediated 
luciferase expression compared to untreated controls (Fig 1C).
Hesperetin protects primary neurones against staurosporine-induced cell death
Hesperetin signalling through ERK may be neuroprotective even in the absence of
changes in CREB mediated gene expression.  In order to test this possibility, primary 
neurones were subjected to a pro-apoptotic insult by exposing them to staurosporine 
(100 nM - 100 M) for 24 h.  Staurosporine induced a concentration-dependent cell 
death as assessed by an MTT endpoint assay (Fig 2A; EC50 = 3.2 M) or by Propidium 
Iodide Hoe 33342 double staining (not shown). In order to test whether hesperetin 
could protect neurones against staurosporine-induced death, cells were incubated with 
hesperetin (100 nM – 10 M) for 24 h before exposure to staurosporine (10 M) for a 
9further 24 h. Neuronal cell death was then measured by propidium iodide and Hoe
33342 double staining.  Staurosporine caused substantial neuronal damage that was 
inhibited by low but not high concentrations of hesperetin (Fig 2B and C).  Maximum 
protection was observed at 300 nM hesperetin (~40 % protection), but at higher 
concentrations protection was lost (Fig 2C) and at the highest concentration tested 
there was evidence of a toxic gain of function
Discussion
These results show that hesperetin, an aglycone flavonoid of the flavanone class 
derived from the diet, enhanced ERK phosphorylation in each of the three different cell 
types used, but only in primary neurones were these effects statistically significant.  In 
neurones, hesperetin had potent effects on ERK phosphorylation i.e was effective at 
concentrations between 100 nM – 300 nM and caused increases in ERK 
phosphorylation about two-fold of control levels. In primary mouse neurones the 
maximal enhancement of ERK phosphorylation by hesperetin was similar to 
(-)epicatechin, but with a lower peak effect, in agreement with previous reports in 
primary neurones [27].  The concentration range in which hesperetin produced
activation of ERK is notable, i.e. it is concentrations in the nanomolar range which are 
the most active.  These concentrations are relevant to the levels which can be obtained 
from the diet, and contrast to the high concentrations of flavonoids that are used in 
many studies of flavonoid biology.  Hesperetin in vitro is known to act as an 
antioxidant and scavenger of peroxynitrite [3,18,19] however at the effective
concentrations in this study, it is unlikely that antioxidant effects of flavonoids mediate
ERK phosphorylation.  Hesperetin may be activating ERK and other kinases through 
direct interactions with the proteins themselves or through receptor-mediated signalling 
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processes.  Indeed, hesperetin has recently been suggested to bind directly to CNS and 
cardiac potassium channels [5,20], and inhibit phosphodiesterase activity [11]. In 
contrast to the stimulatory actions of low concentrations of hesperetin on ERK 
phosphorylation, at the highest concentrations used (10 M), the effects of hesperetin 
were reduced.  This is likely to be due to the effect of flavonoids at these higher 
concentrations activating protein phosphatases or by direct inhibition of effector 
kinases and appears to be a common feature of quercetin [24], (-)epicatechin [23] and 
hesperetin [27] signalling in neurones.
While hesperetin is similar to (-)epicatechin in neurones in stimulating ERK 
phosphorylation, the maximal effect of hesperetin on ERK phosphorylation is lower
than (-)epicatechin and we show here, that unlike (-)epicatechin, hesperetin neither 
induces CREB phosphorylation nor CRE-mediated luciferase expression in neurones.  
Despite this inability to activate CREB-mediated protective pathways, low 
concentrations of hesperetin exerted protective effects against staurosporine-induced 
cell death.  The mechanism underlying this protection is not determined here, but is 
independent of CRE-mediated gene expression is likely to involve ERK-dependent 
regulation of anti-apoptotic signalling pathways. These anti-apoptotic actions are likely 
to involve inhibition of the mitochondrial-associated pro-apoptotic protein, Bad, and 
the apoptosis signal-regulating kinase 1, ASK1 [27]. Thus the study reveals significant 
differences between two flavonoids of different classes, despite an overlap in their 
ability to stimulate phosphorylation of ERK and afford neuroprotection.
The bioactive concentrations of hesperetin identified in our study are likely achievable 
in vivo following feeding. Indeed, hesperidin and/or its metabolite hesperetin are 
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bioactive in vivo, producing sedative [16] and anticonvulsive effects [5] and enhancing
recovery of retinal function after ischaemia in the rat [2]. Overall our data suggests that 
hesperetin can be added to the growing list of dietary-derived polyphenolic compounds 
that exert beneficial actions in the central nervous system.
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Table 1
Effect of hesperetin or (-)epicatechin on ERK phosphorylation in three different cell 
types
mouse primary
cortical 
neurones
human 
neuroblastoma 
SH-SY5Y
human primary 
dermal fibroblasts
hesperetin 100 nM 265 ± 80 (4) ** 166 ± 63 (5) 238 ± 78 (4)
300 nM 187 ± 37 (4) * 219 ± 86 (5) 251 ± 50 (4)
1 M 175 ± 47 (4) 151 ± 44 (5) 192 ± 40 (4)
(-)epicatechin 100 nM 378 ± 40 (4) ** 109 ± 21 (5) 155 ± 22 (4)
300 nM 260 ± 28 (4) ** 189 ± 91 (5) 160 ± 41 (4)
1 M 160 ± 26 (4) 129 ± 21 (5) 187 ± 50 (4) *
Numbers represent means ± SEM of phosphorylated ERK band intensity relative to 
that found in untreated controls.  Number of experiments indicated in brackets. * = 
p<0.05; **= p<0.01, (ANOVA followed by Dunnett’s Multiple Comparison Test).
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Figure Legends
Fig. 1 - Panel A shows representative Western blots probed for phosphorylated
ERK1/2 for primary neurones, SH-SY5Y neuroblastoma and human dermal 
fibroblasts (Promocells) exposed to hesperetin (10 nM – 10 M) for 15 minutes 
before protein extraction.  Panel B shows the effect of hesperetin (10 nM – 10 M) 
for 15 minutes on phosphorylated and total CREB.  Panel C shows the effect of 
overnight incubations with 100 nM or 300 nM hesperetin on CRE-mediated 
luciferase expression in neurones co-transfected with a CRE-firefly luciferase 
reporter plasmid and an internal control plasmid which expressed renilla luciferase.  
Brain-derived neurotrophic factor (50 ng/ml) was used as a positive control to drive 
CRE-mediated gene expression.  Data shows mean luminescence levels, i.e. firefly 
luciferase/Renilla luciferase activities x 10,000.  Error bars are SEM, n = 3. * = 
p<0.05 
Fig. 2 - Effect of staurosporine on cell death was assessed by measurement of MTT 
turnover (Panel A) or (Panel B) by measuring the number of propidum iodide 
positive cells (pink = dead cells) relative to Hoe 33342-stained cells (blue = total 
cells). Panel C shows quantification of protection by hesperetin against 
staurosporine-induced cell death, % Cell death (y axis) is calculated from the 
number of propidum iodide positive cells compared to the number of propidium 
iodide positive cells in the group treated with staurosporine (10 M) alone. Data 
are presented as mean ± SEM. of three independent experiments, each carried out 
in quadruplicate. Comparisons to staurosporine (hatched line = 100%) were 
analysed using one-way analysis of variance (ANOVA), followed by post hoc 
Student–Newman–Keuls multiple range test. * = p < 0.05.
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